Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Signal., 5 April 2011
Vol. 4, Issue 167, p. ec96
[DOI: 10.1126/scisignal.4167ec96]

EDITORS' CHOICE

Immunology Genetics of Candidiasis

Kristen L. Mueller

Science, AAAS, Washington, DC 20005, USA

Chronic mucocutaneous candidiasis disease (CMCD) is characterized by chronic or recurring infection with Candida albicans and, to a lesser extent, with Staphylococcus aureus. The underlying cause of CMCD is unknown. Puel et al. (see the Perspective by Dominguez-Villar and Hafler) now report two genetic etiologies associated with CMCD. The first is an autosomal recessive mutation in interleukin-17 (IL-17) receptor A, which prevents its expression. The second is an autosomal dominant mutation in the cytokine IL-17F, which partially reduces its activity. Thus, human IL-17–mediated immunity is required for protection against these mucocutaneous infections.

A. Puel, S. Cypowyj, J. Bustamante, J. F. Wright, L. Liu, H. K. Lim, M. Migaud, L. Israel, M. Chrabieh, M. Audry, M. Gumbleton, A. Toulon, C. Bodemer, J. El-Baghdadi, M. Whitters, T. Paradis, J. Brooks, M. Collins, N. M. Wolfman, S. Al-Muhsen, M. Galicchio, L. Abel, C. Picard, J.-L. Casanova, Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 332, 65–68 (2011). [Abstract] [Full Text]

M. Dominguez-Villar, D. A. Hafler, An innate role for IL-17. Science 332, 47–48 (2011). [Abstract] [Full Text]

Citation: K. L. Mueller, Genetics of Candidiasis. Sci. Signal. 4, ec96 (2011).



To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882